home.social

#hematology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #hematology, aggregated by home.social.

  1. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  2. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  3. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  4. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  5. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  6. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  7. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  8. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  9. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  10. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  11. US FDA Approves Sanofi’s Wearable Injector Form of Blood Cancer Drug

    The U.S. Food and Drug Administration has approved a wearable injector formulation of Sanofi’s blood cancer drug Sarclisa,…
    #France #FR #Europe #EU #Sanofi #bloodcancer #cancercareinnovation #FDAapproval #hematology #infusiontimereduction #multiplemyeloma #on-bodyinjector #Oncology #Sarclisa #SarclisaEscena #subcutaneousdelivery #wearableinjector
    europesays.com/france/50500/

  12. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  13. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  14. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  15. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  16. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  17. New Atellica HEMA 580 Analyzer from Siemens Healthineers helps labs deliver fast, consistent results to improve clinical decision-making

    Siemens Healthineers now offers U.S. laboratories a comprehensive hematology solution that brings together automation, middleware, and remote digital…
    #Germany #DE #Europe #EU #Europa #Siemens #automation #Blood #Hematology #Laboratory #Morphology #siemens
    europesays.com/germany/50474/

  18. 2026 EHA | Over 40 Orelabrutinib Studies Presented,

    BEIJING, June 15, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
    #Europe #EU #BeijingInnoCarePharmaTechCo. #biotech #EHA #Hematology #HongKongStockExchange:9969 #Ltd. #Orelabrutinib
    europesays.com/europe/69510/

  19. europesays.com/ch/69491/ Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA #Advances #and #ASCO #at #breast #cancer #data #EHA #hematology #in #Innovation #Leadership #new #Novartis #prostate) #reinforces #RLT #With

  20. Higher ferritin threshold could detect childhood iron deficiency much earlier

    Many cases of iron deficiency in school-aged children could be diagnosed earlier, according to a new study published…
    #NewsBeep #News #Health #Anemia #AU #Australia #Blood #Cell #Children #Fatigue #hematology #Hemoglobin #irondeficiency #Menstruation #Nutrition #Obesity #physicalactivity #protein #RedBloodCells
    newsbeep.com/au/683335/

  21. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  22. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  23. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  24. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  25. Intense physical exercise, such as cycling, can rapidly mobilize hematopoietic stem cells into the bloodstream, serving as a potential adjunctive therapy to enhance stem cell donation procedures for conditions like leukemia.
    #Medical #Hematology #CellBiology #Oncology #sflorg
    sflorg.com/2026/05/med05122601

  26. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  27. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  28. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  29. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  30. 🩸 Leukemia - Apr 2026

    • High CD81 expression linked to AML treatment resistance
    • Pediatric AML outcomes improve with refined risk stratification
    • TCR therapy targeting Cathepsin G shows strong cytotoxicity in AML
    • MYB activity drives enhancer activation in leukemia

    pir.sh/mq2dpKK1l4

    #Leukemia #Hematology #Biology

  31. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601

  32. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601

  33. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601

  34. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601

  35. A one-time intravenous infusion of ferric carboxymaltose is a highly effective treatment for iron deficiency anaemia during pregnancy. It rapidly and efficiently restores iron levels compared to traditional daily oral supplements.
    #Obstetrics #Gynaecology #PublicHealth #Hematology #sflorg
    sflorg.com/2026/05/med05042601

  36. X4 Pharmaceuticals Announces European Commission Approval

    – European Commercialization will be Led by X4 Pharmaceuticals’ Partner, Norgine –  – Global, Pivotal Phase 3 Clinical…
    #Europe #EU #drugapproval #European #Hematology #Nasdaq:XFOR #X4Pharmaceuticals
    europesays.com/europe/26220/

  37. X4 Pharmaceuticals Announces European Commission Approval

    – European Commercialization will be Led by X4 Pharmaceuticals’ Partner, Norgine –  – Global, Pivotal Phase 3 Clinical…
    #Europe #EU #drugapproval #European #Hematology #Nasdaq:XFOR #X4Pharmaceuticals
    europesays.com/europe/26109/